Recent News

May 23, 2023 – Read Bayer’s statement on the defense verdict in Gordon here.

March 15, 2023 – Read Bayer’s statement on the filing of the company’s en banc brief before the Eleventh Circuit Court of Appeals in Carson here.

December 19, 2022 – Read Bayer’s statement on the Eleventh Circuit order granting the Company’s petition for rehearing en banc in Carson here.

November 9, 2022 – Read Bayer’s statement on the defense verdict in Ferro here.

September 1, 2022 – Read Bayer’s statement on the defense verdict in Alesi here.

July 12, 2022 – Read Bayer’s statement on the Eleventh Circuit’s decision in Carson here.

June 27, 2022 – Read Bayer’s statement on the Supreme Court’s decision to deny review of Pilliod here.

June 21, 2022 – Read Bayer’s statement on the Supreme Court’s decision to deny review of Hardeman here.

June 17, 2022 – Read Bayer’s statement on the full defense verdict issued in Johnson here.

June 9, 2022 – Read Bayer’s statement on the full defense verdict issued in Shelton here.

May 23, 2022 – Read Bayer’s statement on the Company’s final brief regarding the Petition for Writ of Certiorari in Hardeman here. The full brief can also be read here.

May 10, 2022 – Read Bayer’s statement on the Solicitor General’s brief in the Hardeman appeal here

19December2022

Bayer issues statement on the Eleventh Circuit order granting the Company’s petition for rehearing en banc in Carson here.

Read Bayer's statement  here.

02June2002

Bayer's issues statement on the defense verdict in Ferro.

Read Bayer's statement here.

03June2003

Title

Lorem ipsum dolor sit amet, consectetur adipisicing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit essecillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deserunt mollit anim id est laborum.

About

This site provides information about litigation against Monsanto involving glyphosate-based products (i.e., various Roundup®-branded products.) Bayer has created this site to provide education and resources related to the litigation to media, stakeholders and others with interests relevant to this litigation.

For more information about the litigation, please contact us at info@glyphosatelitigationfacts.com.

Fast Facts on Glyphosate and
Glyphosate-Based Herbicides

  • Long history of safe use: For more than 40 years, farmers – as well as governments, gardeners, and other users – have depended on glyphosate as an efficient and cost-effective tool that can be used safely as directed to control weeds.

  • Conservation benefits: Glyphosate-based herbicides help farmers deliver crops to markets while promoting sustainable farming by reducing soil tillage, soil erosion and carbon emissions.
  • Extensive scientific backing: There is an extensive body of research on glyphosate and Monsanto/Bayer’s glyphosate-based herbicides, including more than 100 studies EPA considered relevant to its cancer risk analysis and more than 800 safety studies overall submitted to regulators, concluding that Bayer’s glyphosate-based herbicides can be used safely as directed and that glyphosate is not carcinogenic.
  • Not carcinogenic: The largest and most recent epidemiology studies, which are the most relevant research for assessing exposure effects in the human population, each found that there was no association between glyphosate-based herbicides and NHL overall in real-world use when adjusted for the use of other pesticides. These include the 2018 independent National Cancer Institute-supported Agricultural Health Study, which followed over 50,000 pesticide applicators for more than 20 years; the 2019 Leon Agricoh Consortium study, which included over 300,000 pesticide applicators; and the 2019 North American Pooled Project, which combined data previously reported in earlier case control studies.

  • Favorable conclusions of regulators and international agencies around the world: The conclusions of leading health authorities around the world, including the U.S. Environmental Protection Agency (EPA), European Food Safety Authority (EFSA), European Chemicals Agency (ECHA), German BfR, and Australian, Canadian, Korean, New Zealand and Japanese regulatory authorities, as well as the Joint FAO/WHO Meeting on Pesticide Residues (JMPR), continue to support the safety of glyphosate‐based products when used as directed and that glyphosate is not carcinogenic. In January 2020, the EPA’s latest interim registration review decision on glyphosate reaffirmed that it “did not identify any human health risks from exposure to glyphosate.”

Recent Media Statements